SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-003387
Filing Date
2019-03-01
Accepted
2019-03-01 10:08:00
Documents
6
Period of Report
2019-02-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k022519_bioxytraninc.htm 8-K 39505
2 FORM OF $250,000 SENIOR SECURED PROMISSORY NOTE, DATED FEBRUARY 25, 2019, OF U.S f8k022519ex10-17_bioxytran.htm EX-10.17 147364
3 FORM OF SECURITY AGREEMENT DATED FEBRUARY 25, 2019, BETWEEN U.S. RARE EARTH MINE f8k022519ex10-18_bioxytran.htm EX-10.18 54679
4 FORM OF WARRANT OF DATED FEBRUARY 25, 2019 f8k022519ex10-19_bioxytran.htm EX-10.19 82092
5 FORM OF REGISTRATION RIGHTS AGREEMENT BETWEEN U.S. RARE EARTH MINERALS, INC. AND f8k022519ex10-20_bioxytran.htm EX-10.20 70383
6 FORM OF SECURITIES PURCHASE AGREEMENT BETWEEN U.S. RARE EARTH MINERALS, INC. AND f8k022519ex10-21_bioxytran.htm EX-10.21 159550
  Complete submission text file 0001213900-19-003387.txt   555244
Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35027 | Film No.: 19647116
SIC: 2834 Pharmaceutical Preparations